Literature DB >> 13790667

The treatment of leprosy.

W H JOPLING.   

Abstract

Entities:  

Keywords:  LEPROSY/therapy

Mesh:

Year:  1960        PMID: 13790667      PMCID: PMC2481895          DOI: 10.1136/pgmj.36.420.634

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  8 in total

1.  Excretion products of 4:4'-diaminodiphenyl sulfone.

Authors:  S R BUSHBY; A J WOIWOD
Journal:  Am Rev Tuberc       Date:  1955-07

2.  Short and long acting sulphones by intramuscular injection.

Authors:  G CURRIE
Journal:  Lepr Rev       Date:  1959-10       Impact factor: 0.537

3.  Some recent chemotherapeutic work in leprosy: with a discussion of some of the problems involved in clinical trials.

Authors:  T F DAVEY
Journal:  Trans R Soc Trop Med Hyg       Date:  1960-05       Impact factor: 2.184

4.  Some aspects of reconstructive surgery in leprosy.

Authors:  J COOK
Journal:  East Afr Med J       Date:  1959-07

5.  A hypermelanotic rash complicating sulphone therapy.

Authors:  S G BROWNE
Journal:  Trans R Soc Trop Med Hyg       Date:  1959-11       Impact factor: 2.184

6.  Initial dosage of diaminodiphenyl sulfone in the treatment of tuberculoid leprosy.

Authors:  R A LEWIS; K KYI-KYI; R EDWARDS
Journal:  Int J Lepr       Date:  1957 Oct-Dec

7.  The place of cortisone and corticotrophin in the treatment of certain acute phases of leprosy.

Authors:  R G COCHRANE; W H JOPLING
Journal:  Lepr Rev       Date:  1957-01       Impact factor: 0.537

8.  1-Methyl-2-mercaptoimidazole; an antithyroid compound highly active in man.

Authors:  M M STANLEY; E B ASTWOOD
Journal:  Endocrinology       Date:  1949-06       Impact factor: 4.736

  8 in total
  1 in total

1.  Leprosy in Africa today.

Authors:  S G BROWNE
Journal:  Postgrad Med J       Date:  1962-02       Impact factor: 2.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.